?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
Katie Quinn
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
February 12, 2019
Katie Quinn
The Biosimilars Forum Objects to Consolidate Billing of Biosimilars
News
February 1, 2019
Katie Quinn
The Biosimilar Forum Recognizes Leah Christl’s Departure from FDA
News
January 31, 2019
Katie Quinn
The Biosimilars Forum Applauds HHS Proposal to Target Costly Rebates Structure Blocking Patients from Biosimilars and Savings
News
December 13, 2018
Katie Quinn
The Biosimilars Forum Commends FDA for Commitment to Increase Patient Access to Biosimilars
News
December 4, 2018
Katie Quinn
Biosimilars Forum Statement on Citizen Petition to the Food and Drug Administration
News
December 3, 2018
Katie Quinn
Biosimilars Forum Announces Launch of Biosimilars Roundtable
News
October 10, 2018
Katie Quinn
New White Paper Finds Biosimilars Could Drive Greater Value Beyond Price for Healthcare System
News
August 9, 2018
Katie Quinn
Biosimilars Forum Statement on CMS Announcement Regarding Medicare Advantage
News
July 18, 2018
Katie Quinn
Biosimilars Forum Applauds Biosimilars Action Plan Released by FDA Commissioner Scott Gottlieb
News
July 16, 2018
Katie Quinn
Biosimilars Forum Submits Comments on HHS Blueprint to Lower Drug Prices
Prev page
01
02
03
04
05
Next page